• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AMGA Appoints Dr. John Kennedy As New Chief Medical Officer

by HITC Staff 01/16/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

AMGA Appoints Dr. John Kennedy As New Chief Medical Officer

AMGA today announced that John W. Kennedy, M.D., has been named chief medical officer, AMGA, and president, AMGA Foundation. Dr. Kennedy previously served as division director of endocrinology at Geisinger Health System in Danville, PA. Dr. Kennedy is board certified in endocrinology, diabetes, and metabolism. He received his Doctor of Medicine degree from Jefferson Medical College, now the Sidney Kimmel Medical College, in Philadelphia, PA. 

Since 2007, Dr. Kennedy has served as division director of endocrinology at Geisinger, where he led the clinical, education, research and quality program development and expansion for the health system.   His achievements included leading Geisinger’s Diabetes Care Transformation Committee in the development of a new diabetes system strategy. Prior to his role at Geisinger, Dr. Kennedy served as managing partner at Diabetes & Endocrinology Associates, P.A., in Hamilton, NJ. There, he transitioned the hospital-owned group into a four physician specialty private practice.

Dr. Kennedy has worked closely with AMGA since 2014 as a national advisor for AMGA’s Together 2 Goal® diabetes campaign, supported by AMGA Foundation. He also serves as chair of Health Transformation Alliance’s Diabetes Clinical Advisory Committee for xG, where he develops diabetes quality care standards for the HTA provider network.

“At Geisinger we saw firsthand the benefits of participating in AMGA’s Together 2 Goal® campaign,” said Dr. Kennedy in a statemnet. “We implemented a strategy that resulted in quality care improvements for more than 35,000 patients with diabetes. Now working with AMGA, I believe I can bring my experience to positively impact patient care at the national level, helping to bring about the transformation of health care in America. I look forward to collaborating with my AMGA colleagues and our members to deliver the highest quality clinical outcomes for patients.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AMGA

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |